Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors

BACKGROUND: Cytopenia is one of the most common adverse events following the CAR-T cell infusion, affecting the quality of life and potentially leading to life-threatening bleeding and infection. This study aimed to systematically review the cytopenias following anti-CD19 CAR-T therapy and further a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yuan, Zhang, Jue, Li, Jing, Zhang, Lina, Li, Jianyong, Fan, Lei, Chen, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673810/
https://www.ncbi.nlm.nih.gov/pubmed/36382675
http://dx.doi.org/10.1080/07853890.2022.2136748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673810/
https://www.ncbi.nlm.nih.gov/pubmed/36382675
http://dx.doi.org/10.1080/07853890.2022.2136748

Ejemplares similares